Paper6137059
Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines.
Kartner N and 2 others. Science, 1983. Cited by 976 papers, by iCite.
Cite this record
ConductScience Library. Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Papers, record 6137059. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6137059
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Resistance | Major topic |
| Glycoproteins | Major topic |
| Membrane Proteins | Major topic |
| ATP Binding Cassette Transporter, Subfamily B, Member 1 | |
| Animals | |
| Cell Line | |
| Cell Membrane Permeability | |
| Molecular Weight |
Source PubMed
Cited by249
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 976 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42388634 | Repurposing loratadine to induce ferroptosis and overcome multidrug resistance: preclinical evidence in KB-V-1 cells. | Front Oncol | 2026 | https://conductscience.org/library/papers/42388634 | PubMed |
| 42240152 | Integrative Chinese Herbal Medicine as Adjuvant Management for Triple-Negative Breast Cancer: A Multi-Institutional Real-World Study With Mechanism Exploration. | Integr Cancer Ther | 2026 | https://conductscience.org/library/papers/42240152 | PubMed |
| 42026237 | Pharmacological strategies to enhance the response of hepatoblastoma to chemotherapy through MDR1 inhibition. | Acta Pharmacol Sin | 2026 | https://conductscience.org/library/papers/42026237 | PubMed |
| 42017162 | Discovery of thieno[3,2-c]pyran-based leads for liver, lung and glioma cancer: synthesis, docking-guided optimization and apoptotic profiling. | RSC Adv | 2026 | https://conductscience.org/library/papers/42017162 | PubMed |
| 40723843 | Predictive and Prognostic Relevance of ABC Transporters for Resistance to Anthracycline Derivatives. | Biomolecules | 2025 | https://conductscience.org/library/papers/40723843 | PubMed |
| 40349292 | A Systematic Review and Classification of the Effects of P-glycoprotein Inhibitors and Inducers in Humans, Using Digoxin, Fexofenadine, and Dabigatran as Probe Drugs. | Clin Pharmacokinet | 2025 | https://conductscience.org/library/papers/40349292 | PubMed |
| 38448649 | Recent Trends in Nanocarrier-Based Drug Delivery System for Prostate Cancer. | AAPS PharmSciTech | 2024 | https://conductscience.org/library/papers/38448649 | PubMed |
| 38291541 | Paclitaxel and its semi-synthetic derivatives: comprehensive insights into chemical structure, mechanisms of action, and anticancer properties. | Eur J Med Res | 2024 | https://conductscience.org/library/papers/38291541 | PubMed |
| 38004460 | Imperatorin Restores Chemosensitivity of Multidrug-Resistant Cancer Cells by Antagonizing ABCG2-Mediated Drug Transport. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/38004460 | PubMed |
| 37864254 | Chemosensitivity to doxorubicin in primary cells derived from tumor of FVB/N-Trp53tm1Hw1 with TALEN-mediated Trp53 mutant gene. | Lab Anim Res | 2023 | https://conductscience.org/library/papers/37864254 | PubMed |
| 37686513 | Genetics of ABCB1 in Cancer. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37686513 | PubMed |
| 37048130 | ABCB1 and ABCG2 Overexpression Mediates Resistance to the Phosphatidylinositol 3-Kinase Inhibitor HS-173 in Cancer Cell Lines. | Cells | 2023 | https://conductscience.org/library/papers/37048130 | PubMed |
| 37017629 | HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies. | J Med Chem | 2023 | https://conductscience.org/library/papers/37017629 | PubMed |
| 36648032 | Histoblot: A sensitive method to quantify the expression of proteins in normal and pathological conditions. | Histol Histopathol | 2023 | https://conductscience.org/library/papers/36648032 | PubMed |
| 36361555 | Hydroxygenkwanin Improves the Efficacy of Cytotoxic Drugs in ABCG2-Overexpressing Multidrug-Resistant Cancer Cells. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36361555 | PubMed |
| 36214609 | MYC and therapy resistance in cancer: risks and opportunities. | Mol Oncol | 2022 | https://conductscience.org/library/papers/36214609 | PubMed |
| 36068781 | The multi-targeted tyrosine kinase inhibitor SKLB610 resensitizes ABCG2-overexpressing multidrug-resistant cancer cells to chemotherapeutic drugs. | Biomed Pharmacother | 2022 | https://conductscience.org/library/papers/36068781 | PubMed |
| 35924580 | Clinical and biological impact of ATP-binding cassette transporter activity in adult acute myeloid leukemia. | Haematologica | 2023 | https://conductscience.org/library/papers/35924580 | PubMed |
| 35897820 | Curcumin Induces Apoptosis of Chemoresistant Lung Cancer Cells via ROS-Regulated p38 MAPK Phosphorylation. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35897820 | PubMed |
| 35861150 | Activation of the integrated stress response is a vulnerability for multidrug-resistant FBXW7-deficient cells. | EMBO Mol Med | 2022 | https://conductscience.org/library/papers/35861150 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6137059
GET https://conductscience.org/api/papers/v1/6137059/cited_by?page=2